MOSQUITOMATE, INC.

Company Information
Address 341 GLENDOVER RD
LEXINGTON, KY, 40503-2010

http://mosquitomate.com

Information

DUNS: 780816091

# of Employees: 8


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Phase II: Feasibility assessment of a novel tool for mosquito vector control: Auto-Dissemination Augmented by Males (ADAM)

    Amount: $597,201.00

    Project summary abstract Mosquito control remains the primary tool for combating many mosquito vectored diseases such as Dengue Chikungunya Zika and West Nile because no approved vaccine therap ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Feasibility assessment of a novel tool for mosquito vector control: Auto-Dissemination Augmented by Males (ADAM)

    Amount: $699,984.00

    DESCRIPTION provided by applicant Vector control remains the only means to combat many important mosquito borne pathogens including the viruses responsible for West Nile Dengue and Chikungunya A key d ...

    SBIRPhase I2016Department of Health and Human Services
  3. Biological vector control reducing arboviruses, including Dengue and Chikungunya

    Amount: $1,799,495.00

    DESCRIPTION provided by applicant In the absence of effective approved drugs or vaccines vector control remains the only means of intervention for many against mosquito borne diseases This probl ...

    SBIRPhase II2014Department of Health and Human Services
  4. Biological vector control reducing arboviruses, including Dengue and Chikungunya

    Amount: $179,379.00

    DESCRIPTION (provided by applicant): In the absence of effective, approved vaccines or therapeutic measures against dengue and other mosquito borne pathogens, public health efforts must focus on the c ...

    SBIRPhase I2012Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government